#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	26834	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2161	1226.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	1445	C,A	1386,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	26834	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2161	1226.6	0	HET	.	.	.	C226T	.	226	226	C	461	461	C	1449	C,T	1088,296	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3544	1388.9	0	.	n	.	0	T695C	SNP	695	695	T	1019	1019	C	1518	C	1463	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3544	1388.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1661	1661	A	1567	A,G	1509,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3544	1388.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2295	2295	C	1525	C	1450	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3544	1388.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2369	2369	A	1497	A,C	1445,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3544	1388.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2921	2921	C	1538	C,G	1491,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	3234	folP	852	852	100.0	folP.l15.c4.ctg.1	1460	219.1	1	SNP	p	R228S	1	.	.	682	684	AGC	994	996	AGC	354;356;356	A,G;G;C	340,1;342;341	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	8800	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3577	243.7	1	SNP	p	S91F	0	.	.	271	273	TCC	729	731	TCC	317;314;316	T;C,T;C	302;298,4;302	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	8800	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3577	243.7	1	SNP	p	D95N	0	.	.	283	285	GAC	741	743	GAC	313;315;318	G,T;A,G,C;C	298,1;289,3,1;300	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	8800	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3577	243.7	1	SNP	p	D95G	0	.	.	283	285	GAC	741	743	GAC	313;315;318	G,T;A,G,C;C	298,1;289,3,1;300	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2734	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1296	208.2	1	SNP	p	G45D	0	.	.	133	135	GGC	408	410	GGC	313;312;311	G;G,A;C	298;299,1;297	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1428	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1086	129.4	0	.	n	.	0	A197.	DEL	197	197	A	545	545	A	353	A	340	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	8570	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2747	308.2	1	SNP	p	D86N	0	.	.	256	258	GAC	460	462	GAC	324;327;334	G;A;C	315;308;322	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	8570	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2747	308.2	1	SNP	p	S88P	0	.	.	262	264	TCC	466	468	TCC	340;339;341	T;C;C	326;326;325	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6876	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2550	266.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1486	1488	GGC	330;322;317	G;G;C	319;314;309	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1254	1256	GCA	383;382;387	G;C;A	360;357;368	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1257	1259	ATC	389;393;388	A;T;C	370;371;365	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1269	1271	GTG	390;388;388	G;T;G,A	368;365;366,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1269	1271	GTG	390;388;388	G;T;G,A	368;365;366,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1773	1775	ACC	323;328;330	A;C;C	298;309;314	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1827	1829	GCG	275;269;269	G;C,G,T;G,A	257;236,4,1;249,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1827	1829	GCG	275;269;269	G;C,G,T;G,A	257;236,4,1;249,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1950	1952	GGC	245;246;242	G,A,T;G;C	231,1,1;230;225	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1959	1961	GGC	223;217;212	G;G;C,G	211;206;203,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	6764	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2445	274.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1977	1979	CCG	174;177;173	C,G;C,G;G	153,6;157,4;148	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	9764	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3143	307.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1656	1658	CCG	329;330;326	C;C,T;G	312;315,1;305	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	7858	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1690	458.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	338	340	GGC	597;596;604	G,A;G;C,T,A	556,2;553;558,1,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	7858	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1690	458.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	520	520	C	535	C,T,G	496,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	D41K	NONSYN	121	123	GAC	392	394	AAA	378;375;378	A,G;A;A	366,1;365;369	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	K46S	NONSYN	136	138	AAA	407	409	AGC	360;356;354	A,G;G,A;C,A	351,1;347,1;346,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	V75I	NONSYN	223	225	GTT	494	496	ATT	337;335;336	A;T,C;T	323;322,1;324	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	T87A	NONSYN	259	261	ACT	530	532	GCT	331;342;344	G,A;C;T	320,2;332;333	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	T89S	NONSYN	265	267	ACC	536	538	AGC	340;337;340	A;G,C;C	330;328,1;332	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	662	664	TAT	352;348;350	T;A,T;T	337;330,3;337	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	N134E	NONSYN	400	402	AAT	671	673	GAG	328;323;332	G,A;A;G,T,A	315,4;314;316,2,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	V135F	NONSYN	403	405	GTG	674	676	TTT	336;335;334	T,G,A;T;T,G	309,3,1;325;319,3	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	G140K	NONSYN	418	420	GGA	689	691	AAA	351;356;355	A,G;A,G;A	333,3;341,2;341	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	698	700	CAA	362;363;369	C,A;A,G,C;A	340,1;341,1,1;347	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	830	832	CGA	405;400;400	C;G;A	386;380;383	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	S189N	NONSYN	565	567	AGC	836	838	AAC	413;416;417	A;A;C	392;390;395	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	A270T	NONSYN	808	810	GCT	1079	1081	ACT	386;385;384	A,G;C;T	369,2;373;375	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1085	1087	GTG	392;393;390	G,A;T;G,A	376,2;371;374,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4680	porB1b	1047	1047	97.13	porB1b.l15.c17.ctg.1	1462	316.4	1	SNP	p	G120K	0	.	.	358	360	GGC	629	631	GGC	324;319;311	G,A;G,A;C,T,G	311,1;305,1;299,2,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	16932	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4959	337.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1858	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1099	167.5	1	SNP	p	V57M	1	.	.	169	171	ATG	583	585	ATG	395;395;398	A;T;G	377;375;378	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
